FTT 0.00% 0.5¢ factor therapeutics limited

Two weeks until trial results, page-23

  1. 85 Posts.
    lightbulb Created with Sketch. 2

    This is normal with many large biomedical companies that consider a product or innovation too disruptive to be released on the market before the expiration of an existing patent. In the end, the worse off are the patients that do not see any progress in their illnesses.

    Big pharma many times buy and store the technology in the shelf.

 
watchlist Created with Sketch. Add FTT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.